flutamide has been researched along with suramin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Crawford, ED; DeAntoni, E | 1 |
| Bell, PR; Horsburgh, T; Kehinde, EO; Mistry, N; Sandhu, DP; Terry, TR | 1 |
| Belldegrun, A; Rosen, P | 1 |
| Eisenberger, MA; Hemady, RK; Jacobs, SC; Jodrell, DI; Lowitt, MH; Reyno, LM; Sinibaldi, VJ; Sridhara, R; Tkaczuk, KH; Zuhowski, EG | 1 |
| Bergan, RC; Cooper, MR; Figg, WD; Headlee, D; Humphrey, J; Reed, E; Sartor, O; Thibault, A | 1 |
| Bergan, RC; Cooper, MR; Dawson, NA; Figg, WD; Headlee, DJ; Myers, CE; Sartor, O; Sausville, EA; Steinberg, SM; Thibault, A | 1 |
| Denis, L; Mahler, C; Verhelst, J | 1 |
| Bitton, RJ; Bowden, CJ; Cooper, MR; Dawson, NA; Figg, WD; Headlee, D; Myers, CE; Reed, E; Sartor, O; Weinberger, MS | 1 |
| Bergan, RC; Cooper, MR; Dawson, NA; Figg, WD; Myers, CE; Reed, E; Sartor, O; Sausville, EA; Senderowicz, AM; Steinberg, SM; Tompkins, A; Weinberger, B | 1 |
| Harbour, D; Liebmann, J; Smith, A | 1 |
1 review(s) available for flutamide and suramin
| Article | Year |
|---|---|
[Recent multicenter study protocols in the USA for patients with metastatic prostatic carcinoma].
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Flutamide; Humans; Leuprolide; Male; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Suramin; Survival Rate; Treatment Outcome | 1995 |
5 trial(s) available for flutamide and suramin
| Article | Year |
|---|---|
UK studies on suramin therapy in hormone resistant prostate cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured | 1995 |
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.
Topics: Adaptation, Physiological; Aged; Anorexia; Bayes Theorem; Cohort Studies; Drug Monitoring; Drug Resistance; Fatigue; Feasibility Studies; Flutamide; Humans; Infusions, Intravenous; Male; Middle Aged; Paresthesia; Prostatic Neoplasms; Remission Induction; Suramin; Survival Rate | 1995 |
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables.
Topics: Aged; Antineoplastic Agents; Flutamide; Humans; Hydrocortisone; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Suramin; Treatment Failure | 1995 |
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Flutamide; Humans; Infusions, Intravenous; Male; Middle Aged; Prostatic Neoplasms; Suramin | 1996 |
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Flutamide; Humans; Leuprolide; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Suramin; Survival Analysis; Treatment Outcome | 1997 |
6 other study(ies) available for flutamide and suramin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
American studies on suramin therapy in hormone resistant prostate cancer.
Topics: Drug Resistance; Flutamide; Humans; Male; Prostatic Neoplasms; Suramin | 1995 |
Acute renal toxicity associated with suramin in the treatment of prostate cancer.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Creatinine; Flutamide; Humans; Hydrocortisone; Kidney; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Suramin | 1994 |
New molecules and treatment modulation in advanced prostatic cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Flutamide; Humans; Imidazoles; Male; Nitriles; Prostatic Neoplasms; Retinoids; Somatostatin; Suramin; Tosyl Compounds | 1996 |
Acute renal failure in a patient receiving treatment with suramin.
Topics: Acute Kidney Injury; Adenocarcinoma; Androgen Antagonists; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Humans; Hydrocortisone; Leuprolide; Lumbar Vertebrae; Male; Middle Aged; Prostatic Neoplasms; Sacrum; Spinal Neoplasms; Suramin; Thoracic Vertebrae | 1997 |